Cargando…
Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis
Site-specific antibody-drug conjugates (ADCs) are designed to overcome the heterogeneity observed with first-generation ADCs that use random conjugation to surface-exposed lysine residues or conjugation to interchain disulfide bonds. Despite significantly enhanced homogeneity, however, the productio...
Autores principales: | Cao, Mingyan, De Mel, Niluka, Jiao, Yang, Howard, James, Parthemore, Conner, Korman, Samuel, Thompson, Christopher, Wendeler, Michaela, Liu, Dengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748582/ https://www.ncbi.nlm.nih.gov/pubmed/31198090 http://dx.doi.org/10.1080/19420862.2019.1624127 |
Ejemplares similares
-
Atypical Asparagine Deamidation of NW Motif Significantly Attenuates the Biological Activities of an Antibody Drug Conjugate
por: Cao, Mingyan, et al.
Publicado: (2023) -
Identification of a CE-SDS shoulder peak as disulfide-linked fragments from common C(H)2 cleavages in IgGs and IgG-like bispecific antibodies
por: Cao, Mingyan, et al.
Publicado: (2021) -
Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody–Drug Conjugate
por: Huang, Yue, et al.
Publicado: (2023) -
Switching positions: Assessing the dynamics of conjugational heterogeneity in antibody–drug conjugates using CE‐SDS
por: van den Berg, Eline B. A., et al.
Publicado: (2022) -
Analytical characterization of coformulated antibodies as combination therapy
por: Kim, Jun, et al.
Publicado: (2020)